124 related articles for article (PubMed ID: 17339190)
1. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Yoshimi A; Baumann I; Führer M; Bergsträsser E; Göbel U; Sykora KW; Klingebiel T; Gross-Wieltsch U; van den Heuvel-Eibrink MM; Fischer A; Nöllke P; Niemeyer C
Haematologica; 2007 Mar; 92(3):397-400. PubMed ID: 17339190
[TBL] [Abstract][Full Text] [Related]
2. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification.
Hasegawa D; Chen X; Hirabayashi S; Ishida Y; Watanabe S; Zaike Y; Tsuchida M; Masunaga A; Yoshimi A; Hama A; Kojima S; Ito M; Nakahata T; Manabe A
Br J Haematol; 2014 Sep; 166(5):758-66. PubMed ID: 24894311
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
[TBL] [Abstract][Full Text] [Related]
5. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Takanashi M; Kadono Y; Tabata Y; Hibi S
Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
Biesma DH; van den Tweel JG; Verdonck LF
Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
[TBL] [Abstract][Full Text] [Related]
8. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
Kelaidi C; Braun T; Arana R; Marceau-Renaut A; Lazarian G; Soret J; Cereja S; Letestu R; Eclache V; Lusina D; Baran-Marszak F; Ades L; Preudhomme C; Martin A; Fenaux P; Gardin C
Leuk Res; 2018 Aug; 71():67-74. PubMed ID: 30025278
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy for myelodysplastic syndromes: refining the indications.
Barrett AJ; Sloand EM
Curr Hematol Malig Rep; 2008 Jan; 3(1):23-8. PubMed ID: 20425443
[TBL] [Abstract][Full Text] [Related]
11. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
[TBL] [Abstract][Full Text] [Related]
13. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
[TBL] [Abstract][Full Text] [Related]
14. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
Yoshimi A; van den Heuvel-Eibrink MM; Baumann I; Schwarz S; Simonitsch-Klupp I; de Paepe P; Campr V; Kerndrup GB; O'Sullivan M; Devito R; Leguit R; Hernandez M; Dworzak M; de Moerloose B; Stary J; Hasle H; Smith OP; Zecca M; Catala A; Schmugge M; Locatelli F; Führer M; Fischer A; Guderle A; Nöllke P; Strahm B; Niemeyer CM
Haematologica; 2014 Apr; 99(4):656-63. PubMed ID: 24162791
[TBL] [Abstract][Full Text] [Related]
15. Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
Barrett J; Sloand E; Young N
Haematologica; 2006 May; 91(5):583-4. PubMed ID: 16670061
[No Abstract] [Full Text] [Related]
16. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome.
Kaito K; Otsubo H; Takei Y; Usui N; Kobayashi M
Ann Hematol; 2003 Nov; 82(11):699-701. PubMed ID: 12961029
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Scheinberg P; Nunez O; Wu C; Young NS
Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
20. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Wesley R; Wang QJ; Barrett AJ
Blood; 2003 Oct; 102(8):3025-7. PubMed ID: 12829603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
